A Phase 2, Multicenter Study of the Efficacy and Safety of bb2121 in Subjects with Relapsed / Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Sponsor
Celgene

Protocol Number
BB2121-MM-001

To Learn More Call
(201)-510-0950